0001415889-24-010091.txt : 20240403
0001415889-24-010091.hdr.sgml : 20240403
20240403172502
ACCESSION NUMBER: 0001415889-24-010091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ragosa Mark
CENTRAL INDEX KEY: 0001835458
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 24820209
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS CORP.
STREET 2: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
form4-04032024_090446.xml
X0508
4
2024-04-01
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001835458
Ragosa Mark
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM 11
BERMUDA
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Class A Common Share
2024-04-01
4
M
0
1750
A
17382
D
Class A Common Share
2024-04-01
4
F
0
514
19.70
D
16868
D
Restricted Share Unit
2024-04-01
4
M
0
1750
0
D
Class A Common Share
1750
5250
D
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.
/s/ Madelyn Zeylikman, Attorney-in-Fact
2024-04-03